{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:10:23Z","timestamp":1790539823643,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["6 H97HA038900-05-01"],"award-info":[{"award-number":["6 H97HA038900-05-01"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jsat.2014.10.010","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T08:17:32Z","timestamp":1415175452000},"page":"70-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infection"],"prefix":"10.1016","volume":"51","author":[{"given":"Jeanette M.","family":"Tetrault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinore F.","family":"McCance-Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie S.","family":"Lruie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An T.","family":"DInh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn E.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jsat.2014.10.010_bb0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","article-title":"Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users","volume":"17","author":"Arnsten","year":"2002","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2014.10.010_bb0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/QAD.0b013e32833407d3","article-title":"Medication-assisted treatment and HIV\/AIDS: Aspects in treating HIV-infected drug users","volume":"24","author":"Bruce","year":"2010","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.jsat.2014.10.010_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/apc.2006.20.399","article-title":"Type of substance use and access to HIV-related health care","volume":"20","author":"Cunningham","year":"2006","journal-title":"AIDS Patient Care & Stds"},{"issue":"6","key":"10.1016\/j.jsat.2014.10.010_bb0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0009-9236(99)90090-5","article-title":"Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships","volume":"65","author":"Dyer","year":"1999","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"Suppl 1","key":"10.1016\/j.jsat.2014.10.010_bb0025","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/QAI.0b013e3182097537","article-title":"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine\/naloxone","volume":"56","author":"Fiellin","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes: JAIDS"},{"issue":"1","key":"10.1016\/j.jsat.2014.10.010_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00952999709001685","article-title":"Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment","volume":"23","author":"Grella","year":"1997","journal-title":"American Journal of Drug & Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.jsat.2014.10.010_bb0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11904-010-0048-2","article-title":"Methadone, buprenorphine, and street drug interactions with antiretroviral medications","volume":"7","author":"Gruber","year":"2010","journal-title":"Current HIV\/AIDS Reports"},{"issue":"2","key":"10.1016\/j.jsat.2014.10.010_bb0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.ftd.0000197094.92559.b4","article-title":"The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"28","author":"Huang","year":"2006","journal-title":"Therapeutic Drug Monitoring"},{"issue":"5","key":"10.1016\/j.jsat.2014.10.010_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/10872910252972285","article-title":"Perceptions of health care among persons living with HIV\/AIDS who are not receiving antiretroviral medications","volume":"16","author":"Kalichman","year":"2002","journal-title":"AIDS Patient Care & Stds"},{"issue":"8","key":"10.1016\/j.jsat.2014.10.010_bb0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.amjcard.2006.06.002","article-title":"Cocaine and methadone: Parallel effects on the QTc interval","volume":"98","author":"Krantz","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1016\/j.jsat.2014.10.010_bb0055","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1592\/phco.2005.25.11.1523","article-title":"Effects of methadone on QT-interval dispersion","volume":"25","author":"Krantz","year":"2005","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology & Drug Therapy"},{"issue":"7","key":"10.1016\/j.jsat.2014.10.010_bb0060","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjcard.2003.11.066","article-title":"Methadone and QT prolongation: A dose-dependent effect?","volume":"93","author":"Krantz","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1016\/j.jsat.2014.10.010_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: Review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2014.10.010_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J069v26n01_08","article-title":"Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program","volume":"26","author":"Maremmani","year":"2007","journal-title":"Journal of Addictive Diseases"},{"issue":"4","key":"10.1016\/j.jsat.2014.10.010_bb0085","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/376907","article-title":"The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients","volume":"37","author":"McCance-Katz","year":"2003","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2014.10.010_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1521-0391.2009.00009.x","article-title":"Effect of cocaine use on methadone pharmacokinetics in humans","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"American Journal on Addictions"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2014.10.010_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.drugalcdep.2007.06.007","article-title":"Interaction between buprenorphine and atazanavir or atazanavir\/ritonavir","volume":"91","author":"McCance-Katz","year":"2007","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.10.010_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1521-0391.2009.00001.x","article-title":"Effect of cocaine use on buprenorphine pharmacokinetics in humans","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"American Journal on Addictions"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2014.10.010_bb0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0899-3289(01)00064-5","article-title":"Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users","volume":"13","author":"Metsch","year":"2001","journal-title":"Journal of Substance Abuse"},{"issue":"3","key":"10.1016\/j.jsat.2014.10.010_bb0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jat\/32.3.208","article-title":"An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes","volume":"32","author":"Moody","year":"2008","journal-title":"Journal of Analytical Toxicology"},{"issue":"4","key":"10.1016\/j.jsat.2014.10.010_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00126334-199908010-00006","article-title":"Access to and utilization of primary care services among HIV-infected women","volume":"21","author":"Palacio","year":"1999","journal-title":"Journal of Acquired Immune Deficiency Syndromes: JAIDS"},{"issue":"3","key":"10.1016\/j.jsat.2014.10.010_bb0110","first-page":"515","article-title":"Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine","volume":"23","author":"Pellinen","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jsat.2014.10.010_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/B:JOHE.0000016716.99847.9b","article-title":"Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women","volume":"29","author":"Sharpe","year":"2004","journal-title":"Journal of Community Health"},{"issue":"4","key":"10.1016\/j.jsat.2014.10.010_bb0120","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1081\/ADA-120026256","article-title":"Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence","volume":"29","author":"Sofuoglu","year":"2003","journal-title":"American Journal of Drug & Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2014.10.010_bb0125","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1089\/apc.2007.9985","article-title":"Type and pattern of illicit drug use and access to health care services for HIV-infected people","volume":"21","author":"Sohler","year":"2007","journal-title":"AIDS Patient Care & Stds"},{"issue":"Suppl 1","key":"10.1016\/j.jsat.2014.10.010_bb0130","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/QAI.0b013e3182097576","article-title":"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine\/naloxone","volume":"56","author":"Sullivan","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes: JAIDS"},{"key":"10.1016\/j.jsat.2014.10.010_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1521-0391.2009.00003.x","article-title":"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine\/naloxone for the treatment of opioid dependence","volume":"19","author":"Sullivan","year":"2010","journal-title":"American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.jsat.2014.10.010_bb0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jsat.2012.07.011","article-title":"Brief versus extended counseling along with buprenorphine\/naloxone for HIV-infected opioid dependent patients","volume":"43","author":"Tetrault","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.jsat.2014.10.010_bb0145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(03)00093-7","article-title":"Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection","volume":"114","author":"Tucker","year":"2003","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2014.10.010_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002030-199902040-00014","article-title":"A prospective study of HIV disease progression in female and male drug users","volume":"13","author":"Webber","year":"1999","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jsat.2014.10.010_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09595230500537381","article-title":"The association between cocaine use and short-term outcomes for the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS)","volume":"25","author":"Williamson","year":"2006","journal-title":"Drug & Alcohol Review"},{"issue":"3","key":"10.1016\/j.jsat.2014.10.010_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.drugalcdep.2005.08.010","article-title":"The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence","volume":"81","author":"Williamson","year":"2006","journal-title":"Drug & Alcohol Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214002219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214002219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:42:52Z","timestamp":1760038972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547214002219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":32,"alternative-id":["S0740547214002219"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2014.10.010","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2014.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}